Mutations in NaV1.1 have been associated with epilepsy exhibiting a wide spectrum of severity, including Dravet syndrome and genetic epilepsy with febrile seizures plus (GEFS+) [1, 3]. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.